ATE274340T1 - Zelleinkapselungsvorrichtung - Google Patents

Zelleinkapselungsvorrichtung

Info

Publication number
ATE274340T1
ATE274340T1 AT98124882T AT98124882T ATE274340T1 AT E274340 T1 ATE274340 T1 AT E274340T1 AT 98124882 T AT98124882 T AT 98124882T AT 98124882 T AT98124882 T AT 98124882T AT E274340 T1 ATE274340 T1 AT E274340T1
Authority
AT
Austria
Prior art keywords
permeable membrane
core
devices
cells
cell encapsulating
Prior art date
Application number
AT98124882T
Other languages
English (en)
Inventor
Mark D Butler
Stanley L Mish
Original Assignee
Gore & Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gore & Ass filed Critical Gore & Ass
Application granted granted Critical
Publication of ATE274340T1 publication Critical patent/ATE274340T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Optical Measuring Cells (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Transplanting Machines (AREA)
AT98124882T 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung ATE274340T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10501193A 1993-08-10 1993-08-10

Publications (1)

Publication Number Publication Date
ATE274340T1 true ATE274340T1 (de) 2004-09-15

Family

ID=22303587

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98124882T ATE274340T1 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung
AT94922456T ATE183078T1 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94922456T ATE183078T1 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung

Country Status (9)

Country Link
US (2) US5980889A (de)
EP (2) EP0938893B1 (de)
AT (2) ATE274340T1 (de)
AU (1) AU678843B2 (de)
CA (1) CA2147626C (de)
DE (3) DE938893T1 (de)
DK (1) DK0663817T3 (de)
ES (1) ES2138665T3 (de)
WO (1) WO1995004521A1 (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE274340T1 (de) * 1993-08-10 2004-09-15 Gore & Ass Zelleinkapselungsvorrichtung
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
AU6854696A (en) * 1995-09-22 1997-04-09 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
US5855613A (en) 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
US6306491B1 (en) * 1996-12-20 2001-10-23 Gore Enterprise Holdings, Inc. Respiratory aids
AU8577498A (en) * 1997-07-22 1999-02-16 General Hospital Corporation, The Modulation of multicellular aggregates by solid stress
US6287558B1 (en) * 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
US6984635B1 (en) 1998-02-13 2006-01-10 Board Of Trustees Of The Leland Stanford Jr. University Dimerizing agents, their production and use
US6303136B1 (en) * 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
RU2142810C1 (ru) * 1998-07-28 1999-12-20 Григорьянц Рубен Исаакович Бионическое устройство для лечения сахарного диабета
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
US20020095157A1 (en) 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
US20010031974A1 (en) * 2000-01-31 2001-10-18 Hadlock Theresa A. Neural regeneration conduit
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US20020127265A1 (en) * 2000-12-21 2002-09-12 Bowman Steven M. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6852330B2 (en) * 2000-12-21 2005-02-08 Depuy Mitek, Inc. Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CZ298160B6 (cs) * 2001-01-18 2007-07-11 Prístroj pro vyvolání imunitní odezvy pri lécbe rakoviny
AU2002310361A1 (en) * 2001-06-08 2002-12-23 Boehringer Ingelheim Pharmaceuticals, Inc. Methods for improving cell line activity in immunoisolation devices
EP1423133B1 (de) 2001-08-15 2009-01-14 Brown University Research Foundation Behandlung von muskeldystrophien und verwandter erkrankungen
AU2003216436A1 (en) 2002-02-08 2003-09-02 Life Technologies Corporation Compositions and methods for restoring immune responsiveness in patients with immunological defects
US20030170278A1 (en) * 2002-03-11 2003-09-11 Wolf David E. Microreactor and method of determining a microreactor suitable for a predetermined mammal
AU2003253684A1 (en) 2002-06-28 2004-01-19 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040078090A1 (en) 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
WO2004075855A2 (en) 2003-02-26 2004-09-10 Biomed Solutions, Llc Process for in vivo treatment of specific biological targets in bodily fluid
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
DK1623017T3 (da) * 2003-05-08 2011-01-10 Life Technologies Corp Frembringelse og isolering af antigenspecifikke T-celler
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
GB2407394A (en) 2003-10-23 2005-04-27 Dow Corning Ltd Optical waveguide with two differently dimensioned waveguiding layers on substrate
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8657881B2 (en) 2004-04-20 2014-02-25 Depuy Mitek, Llc Meniscal repair scaffold
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US20060257368A1 (en) * 2005-05-03 2006-11-16 Clemson University Devices and methods for improved viability of cells
US20090196854A1 (en) * 2008-02-04 2009-08-06 Kytos Biosystems S.A. Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
US20100080784A1 (en) * 2008-09-12 2010-04-01 Torrey Pines Institute For Molecular Studies Methods for treating cachexia and lymphopenia
WO2010083841A2 (en) 2009-01-23 2010-07-29 Nsgene A/S Improved cell lines and their use in encapsulated cell biodelivery
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
DK2621403T3 (en) 2010-09-27 2015-06-15 Nsgene As An implantable cell device with supporting and radial diffusible structure
US9958458B2 (en) 2010-12-27 2018-05-01 Brown University Therapeutic and diagnostic methods involving biglycan and utrophin
JP2014525338A (ja) * 2011-09-06 2014-09-29 ステム セル サージカル リミテッド ライアビリティ カンパニー 手術用縫合糸ならびにその作製および使用の方法
EP2807250B1 (de) 2011-11-23 2020-01-08 The Trustees Of The University Of Pennsylvania Verwendung von pdl1-exprimierenden zellen zur umwandlung von t-zellen in regulatorische t-zellen
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10203295B2 (en) 2016-04-14 2019-02-12 Lockheed Martin Corporation Methods for in situ monitoring and control of defect formation or healing
US10418143B2 (en) 2015-08-05 2019-09-17 Lockheed Martin Corporation Perforatable sheets of graphene-based material
US10980919B2 (en) 2016-04-14 2021-04-20 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
USD720469S1 (en) 2013-03-07 2014-12-30 Viacyte, Inc. Cell encapsulation device
US9592475B2 (en) 2013-03-12 2017-03-14 Lockheed Martin Corporation Method for forming perforated graphene with uniform aperture size
JP6392315B2 (ja) 2013-03-14 2018-09-19 イミュソフト コーポレーション インビトロでのメモリーｂ細胞分化方法およびｖｓｖ−ｇ偽型ウイルスベクターを用いる形質導入方法
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
JP2017510461A (ja) 2014-01-31 2017-04-13 ロッキード マーティン コーポレイションＬｏｃｋｈｅｅｄ Ｍａｒｔｉｎ Ｃｏｒｐｏｒａｔｉｏｎ 広幅イオン場を用いる二次元材料の穿孔
AU2015210875A1 (en) 2014-01-31 2016-09-15 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
USD718468S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718470S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718466S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-Dimensional large capacity cell encapsulation device
USD718469S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718471S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD714956S1 (en) * 2014-03-07 2014-10-07 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718467S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718472S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
WO2015138771A1 (en) 2014-03-12 2015-09-17 Lockheed Martin Corporation Separation membranes formed from perforated graphene
SG11201701654UA (en) 2014-09-02 2017-04-27 Lockheed Corp Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
CA2966035A1 (en) 2014-10-31 2016-05-06 The Trustees Of The University Of Pennsylvania Compositions and methods of stimulating and expanding t cells
KR102546296B1 (ko) 2014-10-31 2023-06-21 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 변형된 t 세포에서 유전자 발현의 변경 및 그의 용도
CN107106670A (zh) 2014-10-31 2017-08-29 宾夕法尼亚大学董事会 用于修饰的t细胞的方法和组合物
WO2016100932A1 (en) 2014-12-19 2016-06-23 Immusoft Corporation B cells for in vivo delivery of therapeutic agents
CA2975147C (en) 2015-01-31 2025-06-10 The Trustees Of The University Of Pennsylvania COMPOSITIONS AND METHODS OF ADMINISTRATION OF THERAPEUTIC MOLECULES TO T CELLS
EP3730515B1 (de) 2015-02-16 2023-07-26 The Trustees of the University of Pennsylvania Vollhumaner t-zellrezeptor spezifisch für das 369 377-epitop aus dem her2/neu (erbb2)-rezeptorprotein
AU2016303049A1 (en) 2015-08-06 2018-03-01 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
WO2017147431A1 (en) * 2016-02-24 2017-08-31 Georgia Tech Research Corporation Surgical suture materials with porous sheaths for drug delivery
SG11201809015WA (en) 2016-04-14 2018-11-29 Lockheed Corp Two-dimensional membrane structures having flow passages
SG11201808962RA (en) 2016-04-14 2018-11-29 Lockheed Corp Method for treating graphene sheets for large-scale transfer using free-float method
CA3020880A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
CN109790508A (zh) * 2016-06-28 2019-05-21 国立研究开发法人农业·食品产业技术综合研究机构 细胞封入用设备及其用途
EP3534834A4 (de) 2016-11-03 2020-05-13 Arizona Board of Regents on behalf of the University of Arizona Verkapselungsvorrichtungssysteme mit sauerstoffsensoren mit oder ohne exogener sauerstoffzufuhr
SG10202104564SA (en) 2016-11-03 2021-06-29 Univ Arizona Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
CN116919648A (zh) 2016-11-03 2023-10-24 代表亚利桑那大学的亚利桑那董事会 有或无氧气输送的堆叠组织包封装置的系统
US11707611B2 (en) 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
US11052230B2 (en) 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
EP3537986B1 (de) 2016-11-10 2025-06-18 ViaCyte, Inc. Pdx1-pankreatische endodermzellen in zelleneinführungsvorrichtungen
US12247060B2 (en) 2018-01-09 2025-03-11 Marengo Therapeutics, Inc. Calreticulin binding constructs and engineered T cells for the treatment of diseases
WO2019178362A1 (en) 2018-03-14 2019-09-19 Elstar Therapeutics, Inc. Multifunctional molecules that bind to calreticulin and uses thereof
AU2019233929B2 (en) 2018-03-16 2025-05-29 Immusoft Corporation B cells genetically engineered to secrete follistatin and methods of using the same to treat follistatin-related diseases, conditions, disorders and to enhance muscle growth and strength
JP7554742B2 (ja) 2018-07-03 2024-09-20 マレンゴ・セラピューティクス，インコーポレーテッド 抗ｔｃｒ抗体分子およびその使用
TW202031210A (zh) * 2018-09-24 2020-09-01 美國亞利桑那州大學董事會 用於可植入式醫療裝置及血管化薄膜之方法及系統
AU2020226893B2 (en) 2019-02-21 2025-02-27 Marengo Therapeutics, Inc. Multifunctional molecules that bind to T cell related cancer cells and uses thereof
GB2597851B (en) 2019-02-21 2024-05-29 Marengo Therapeutics Inc Antibody molecules that bind to NKP30 and uses thereof
GB2609554B (en) 2020-01-03 2025-08-20 Marengo Therapeutics Inc Anti-TCR antibody molecules and uses thereof
CN116761652A (zh) 2020-10-30 2023-09-15 亚利桑那大学董事会 用于容纳细胞和试剂的封装设备的方法和系统
WO2025096730A1 (en) 2023-11-01 2025-05-08 University Of Virginia Patent Foundation Novel autoregulated car t cells and uses thereof
WO2025106856A1 (en) 2023-11-15 2025-05-22 Immusoft Corporation Migratory modified differentiated b cells for cancer therapy
WO2025147573A2 (en) 2024-01-05 2025-07-10 Immusoft Corporation Glp-1 expressing modified b cells for the treatment of metabolic disease

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
CA1085104A (en) * 1977-03-21 1980-09-09 Anthony M. Sun Artificial endocrine pancreas
US4743545A (en) * 1984-08-09 1988-05-10 Torobin Leonard B Hollow porous microspheres containing biocatalyst
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4420589A (en) * 1980-07-07 1983-12-13 Stoy Vladimir A Polymer composition including polyacrylonitrile polymers and process for preparing same
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4495288A (en) * 1981-03-13 1985-01-22 Damon Biotech, Inc. Method of culturing anchorage dependent cells
US4378016A (en) * 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
WO1984001287A1 (en) * 1982-09-29 1984-04-12 Theodore E Spielberg Encapsulated genetically programmed living organisms producing therapeutic substances
CA1196862A (en) * 1983-06-01 1985-11-19 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4806355A (en) * 1983-06-06 1989-02-21 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4803168A (en) * 1983-09-01 1989-02-07 Damon Biotech, Inc. Microencapsulation with polymers
EP0147939A2 (de) * 1983-11-15 1985-07-10 JOHNSON & JOHNSON Einpflanzbarer Modul zur Regulierung der Glykämie
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4722898A (en) * 1985-04-29 1988-02-02 Minnesota Mining And Manufacturing Company Immobilization of biological cells in polytetrafluoroethylene matrix
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
AU589438B2 (en) * 1985-08-26 1989-10-12 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US5030225A (en) * 1987-03-13 1991-07-09 Brown University Research Foundation Electrically-charged nerve guidance channels
US5218039A (en) * 1987-04-28 1993-06-08 Kingston Technologies, Inc. Pan emulsion
US4911717A (en) * 1987-06-18 1990-03-27 Gaskill Iii Harold V Intravasular artificial organ
US4942129A (en) * 1987-07-28 1990-07-17 Queen's University At Kingston Multiple membrane microencapsulation
US5106627A (en) * 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5418154A (en) * 1987-11-17 1995-05-23 Brown University Research Foundation Method of preparing elongated seamless capsules containing biological material
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
JPH037751A (ja) * 1988-03-04 1991-01-14 Kingston Technol Ltd Partnership 新規ポリアクリロニトリル組成物およびその製造方法
US5081035A (en) * 1988-04-18 1992-01-14 The University Of Michigan Bioreactor system
US4941812A (en) * 1988-05-10 1990-07-17 E. I. Du Pont De Nemours And Company Spinneret for production of a hollow filament within a hollow filament composite fiber having spacing means
FR2634382B1 (fr) * 1988-07-21 1990-10-26 Applic Techn Photoniques Pancreas artificiel
WO1990001498A1 (en) * 1988-08-12 1990-02-22 Cell Biotech, Inc. Process for purification of islet cells; monoclonal antibodies directed to islet and acinar cells; and process for making and using same
CA1323959C (en) * 1988-09-16 1993-11-09 Andreas F. Von Recum Soft tissue implant with micron-scale surface texture to optimize anchorage
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
US5017490A (en) * 1989-03-10 1991-05-21 Baxter International Inc. Method for in vitro reproduction and growth of cells in culture medium
CA2031532C (en) * 1989-04-25 2003-02-25 Joseph P. Vacanti Method for implanting large volumes of cells on polymeric matrices
KR0141583B1 (ko) * 1989-06-21 1998-06-15 윌리암 엠. 잭슨 신경병 치료장치
WO1991000119A1 (en) * 1989-06-30 1991-01-10 Baxter International Inc. Implantable device
US5116494A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with temperature sensitive matrix
US5002661A (en) * 1989-08-25 1991-03-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device
US5116493A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with reseedable matrix
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
WO1991010470A1 (en) * 1990-01-08 1991-07-25 Brown University Research Foundation Devices and methods for enhanced delivery of active factors
US4969705A (en) * 1990-01-19 1990-11-13 Kingston Technologies, L.P. Memory polymer multiple cavity fiber splicer
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5256418A (en) * 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
BR9106205A (pt) * 1990-10-31 1993-03-30 Baxter Int Dispositivo para implantacao em hospedeiro,processo de implantacao,dispositivo implantado,e recipiente de imunoisolamento
DE4108772A1 (de) * 1991-03-18 1992-09-24 Inst Textil & Faserforschung Implantierbares biohybrides organ
CA2109085C (en) * 1991-04-25 2003-03-11 Keith E. Dionne Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
WO1993008850A1 (en) * 1991-10-30 1993-05-13 Massachusetts Institute Of Technology Prevascularized polymeric implants for organ transplantation
CA2132016A1 (en) * 1992-04-01 1994-10-14 Baxter International Inc. Angiogenic tissue implant systems and methods
AU4114993A (en) * 1992-04-24 1993-11-29 Polymer Technology Group, Inc., The Biocompatible, therapeutic, implantable device
WO1993022427A1 (en) * 1992-04-24 1993-11-11 Somatix Therapy Corporation Method of culturing viable cells and method of regulating the level of a compound in a body fluid
EP0663951B1 (de) * 1992-09-28 2002-06-05 Brown University Research Foundation Chitozanmatrizes für eingekapselte zellen
ATE274340T1 (de) * 1993-08-10 2004-09-15 Gore & Ass Zelleinkapselungsvorrichtung
DK0688196T3 (da) * 1994-01-11 2002-06-03 Baxter Int Med åbninger forsynede implantatsystemer

Also Published As

Publication number Publication date
DE69433970D1 (de) 2004-09-30
DE69433970T2 (de) 2005-08-11
AU7356394A (en) 1995-02-28
EP0663817B1 (de) 1999-08-11
CA2147626A1 (en) 1995-02-16
DE938893T1 (de) 2000-03-09
ES2138665T3 (es) 2000-01-16
DK0663817T3 (da) 2000-03-13
US6426214B1 (en) 2002-07-30
ATE183078T1 (de) 1999-08-15
DE69420024T2 (de) 2000-02-24
WO1995004521A1 (en) 1995-02-16
AU678843B2 (en) 1997-06-12
EP0938893A1 (de) 1999-09-01
CA2147626C (en) 1998-04-21
EP0663817A1 (de) 1995-07-26
DE69420024D1 (de) 1999-09-16
US5980889A (en) 1999-11-09
EP0938893B1 (de) 2004-08-25

Similar Documents

Publication Publication Date Title
ATE183078T1 (de) Zelleinkapselungsvorrichtung
AU2544201A (en) Implantable device
FI930883A0 (fi) In vivo -dosering av aktiva faktorer med hjaelp av samodlade cellimplantat
DK463586A (da) Fsh
KR960703343A (ko) 밀봉주입식 박막 캡슐장치 및 그 제조방법(method and apparatus for sealing implantable, membrane encapsulation devices)
ES2173142T3 (es) Dispositivo y procedimiento para la captura y recuperacion de celulas.
ES2012944A6 (es) Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.
ATE350068T1 (de) Terminal-sterilisierte osteogene vorrichtungen und ihre herstellung
DK0802800T3 (da) Biokompatible immunoisolatoriske kapsler indeholdende genetisk ændrede celler for levering af biologisk aktive molekyler
ES2150563T3 (es) Sistema de electrotransporte con sistema de liberacion de medicamento mejorado.
ATE308999T1 (de) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
CA2346644A1 (en) Method for preventing xenograft transplant rejection using photodynamic therapy
AU6389086A (en) A method for the treatment of atherosclerosis, thrombosis and peripheral vesseldisease
ATE410054T1 (de) Durch elektroporation vermittelter molekulartransfer in intakten pflanzen
TW332827B (en) UV absorber
NO975545L (no) Cellelinje som produserer analgetiske forbindelser for behandling av smerte
IT1250659B (it) Procedimento di purificazione di carragenine commerciali
DK161320C (da) Analogifremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thiophener
FR2695828B1 (fr) Dispositif de décontamination de déchets.
CY1108126T1 (el) Μεθοδοι ελεγχου διαφοροποιησης και αναπτυξης κυτταρου χρησιμοποιωντας πρωτεϊνη συντηξης και ενα φαρμακο
CA2129403A1 (en) Ion Implanting Apparatus and Ion Implanting Method
ES8405224A1 (es) "perfeccionamientos introducidos en un aparato perceptor del nivel de corriente representativa de imagen en negro en un sistema de tratamiento de senales de video".
ATE102655T1 (de) Extraktion von menschlichem interleukin-4 aus bakterien.
DE3483850D1 (de) Tablette mit kontrollierter freigabe.
DK372389D0 (da) Apparat til jordbehandling, specielt ved hjaelp af knusning og sammenpresning

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties